American Century Companies’s Terns Pharmaceuticals TERN Stock Holding History

American Century Companies's TERN Position: Q1 2026 in Review

American Century Companies sold out of Terns Pharmaceuticals (TERN) in Q1 2026, closing a stake of 192,751 shares — an estimated $7.79M sold.

American Century Companies first reported a position in TERN in Q2 2023 and held it in 11 quarters. The position peaked at $7.79M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

• American Century Companies reported no remaining Terns Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
• American Century Companies sold 192,751 Terns Pharmaceuticals shares in Q1 2026, an estimated $7.79M.
• American Century Companies first reported a position in Terns Pharmaceuticals in Q2 2023 and held it in 11 quarters.
• American Century Companies's Terns Pharmaceuticals position peaked at $7.79M in Q4 2025.
• 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.